French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M
THE SO WHAT
A €30M Series A into pharma-focused SaaS is another data point that deep vertical software—especially in regulated, data-rich sectors—still commands real capital. If you’re horizontal in health or life sciences, expect more pressure from specialists who can encode domain nuance directly into workflows.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureAs Software VCs Chase SpaceX Alumni, A Defense Tech Veteran Warns Of ‘Tourists And FOMO’
Software VCs chasing SpaceX alumni into industrial and defense tech, while sector veterans warn of ‘tourists,’ is a reminder that hardware timelines and risk don’t bend to SaaS instincts. If you’re building in this space, prioritize investors and partners who understand certification, supply chains, and unit economics over headline valuations.
Startups & VentureFintechOS raises $28M in equity and debt after turning profitable
A profitable AI-first core for banks and insurers raising $28M in mixed equity and senior debt is a data point for where late-stage capital is comfortable—vertical, regulated, and already in production. If you sell AI into financial services, expect buyers to benchmark you against this kind of operational discipline and domain depth.
Startups & VentureSpott raises $21M Series A led by Balderton for its AI platform for recruitment agencies
A $21M Series A for an AI-native ATS and CRM aimed specifically at recruitment agencies shows how fast 'horizontal HR tech' is being unbundled. If you run staffing or talent operations, evaluate whether your current stack can keep pace with AI-driven sourcing and outreach or if a vertical tool like this becomes table stakes.
Startups & VentureBiolevate raises €30M Series A and opens Boston office for its life sciences AI
€30M into Biolevate’s AI automation for regulated life sciences — plus a Boston beachhead — is another data point that pharma and medtech workflows are becoming software-first. If you operate in GxP environments, expect buyers and regulators to normalize AI-driven automation and start budgeting for validated, audit-friendly tooling.